Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer

JR Mekala, SM Naushad, L Ponnusamy… - Gene, 2018 - Elsevier
MicroRNAs (miRNAs) are a class of small, non-coding RNAs that are involved in the
regulation of gene expression at the post-transcriptional level. MicroRNAs play an important …

Tumor suppressor microRNAs: Targeted molecules and signaling pathways in breast cancer

F Asghari, N Haghnavaz, B Baradaran… - Biomedicine & …, 2016 - Elsevier
Breast cancer is the most common type of cancer in women whose prevalence is increasing
every year. Common strategies for diagnosis, prognosis and specific treatment of breast …

MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment

PJ Kaboli, A Rahmat, P Ismail, KH Ling - Pharmacological research, 2015 - Elsevier
Abstract MicroRNAs (miRNA) are 21–23 nucleotide molecules not translated into proteins
that bind and target the 3′ untranslated regions of mRNA. These characteristics make them …

MicroRNAs-mediated cell fate in triple negative breast cancers

X Sui, X Wang, W Han, D Li, Y Xu, F Lou, J Zhou, X Gu… - Cancer Letters, 2015 - Elsevier
MicroRNAs (miRNAs) are small non-coding RNAs that function as major modulators of
posttranscriptional protein-coding gene expression in diverse biological processes including …

[HTML][HTML] From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment

R Piva, DA Spandidos… - … journal of oncology, 2013 - spandidos-publications.com
MicroRNAs (miRNAs or miRs) are a family of small non‑coding RNAs that regulate gene
expression by the sequence-selective targeting of mRNAs, leading to translational …

MicroRNAs as regulatory elements in triple negative breast cancer

MT Gyparaki, EK Basdra, AG Papavassiliou - Cancer letters, 2014 - Elsevier
Triple negative breast cancer is a very aggressive subtype of breast cancer characterized by
high recurrence rates and a greater likelihood of death compared to other breast cancers …

MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylation

SK Surapaneni, ZR Bhat, K Tikoo - Scientific reports, 2020 - nature.com
Breast cancer including triple negative breast cancer (TNBC) represents an important
clinical challenge, as these tumours often develop resistance to conventional …

Potential miRNAs for miRNA-based therapeutics in breast cancer

JS Wong, YK Cheah - Non-coding RNA, 2020 - mdpi.com
MicroRNAs (miRNAs) are small non-coding RNAs that can post-transcriptionally regulate
the genes involved in critical cellular processes. The aberrant expressions of oncogenic or …

Let-7, miR-125, miR-205, and miR-296 are prospective therapeutic agents in breast cancer molecular medicine.

D Barh, S Parida, BP Parida… - Gene Therapy & …, 2008 - search.ebscohost.com
Increasing evidences in recent years demonstrate that several biological processes and
disease pathogenesis are regulated by micro RNAs (miRs) and restoration of normal miR …

Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer

J Hu, J Xu, Y Wu, Q Chen, W Zheng, X Lu, C Zhou… - Tumor Biology, 2015 - Springer
MicroRNAs (miRNAs) are widely recognized as key players in cancer progression and drug
resistance, but less is known about the role of miRNAs in triple-negative (estrogen receptor …